X'PROCHEM

📍 Loos, France🗓 Founded 2012👥 13 employees💰 Last funded Jun 2018
Biotechnology Research🌐 xprochem.com
Website LinkedIn
X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in X'PROCHEM?
X'PROCHEM has 1 investor on record on gritt.io and 1 late-stage investors.
When did X'PROCHEM last raise funding?
The most recent investment in X'PROCHEM recorded on gritt.io was in June 2018.
When was X'PROCHEM founded?
X'PROCHEM was founded in 2012.
What industry is X'PROCHEM in?
X'PROCHEM operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is X'PROCHEM based?
X'PROCHEM is headquartered in Loos, France.